Gene · 23600
Papers2,301
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,301
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunostaining for polycomb group protein EZH2 as a diagnostic tool to differentiate urothelial carcinoma in situ from benign lesions. | Hum Pathol | 2025 | 40456417 | PubTator, text mining | PubMed |
| Small papillary renal neoplasm with reverse polarity (≤ 15 mm) may challenge the current diagnostic criteria of papillary adenoma. | Virchows Arch | 2025 | 40448848 | PubTator, text mining | PubMed |
| Renal oncocytoma with liver metastasis: a case report with genetic analysis and literature review. | Front Med (Lausanne) | 2025 | 40370715 | PubTator, text mining | PubMed |
| Deep learning assisted identification of SCUBE2 and SLC16 A5 combination in RNA-sequencing data as a novel specific potential diagnostic biomarker in prostate cancer. | Med Biol Eng Comput | 2025 | 40335872 | PubTator, text mining | PubMed |
| Programmable spherical nucleic acids integrated with MOF-confined copper nanoclusters facilitate electrochemiluminescence detection of prostate-specific biomarkers. | J Mater Chem B | 2025 | 40271962 | PubTator, text mining | PubMed |
| Bilateral primary ovarian clear cell carcinoma in a multiparous perimenopausal woman. | Rev Esp Patol | 2025 | 40252630 | PubTator, text mining | PubMed |
| Primary urethral adenocarcinoma harbors recurrent KRAS and EGFR alterations. | Hum Pathol | 2025 | 40194726 | PubTator, text mining | PubMed |
| Eosinophilic solid and cystic renal cell carcinoma: A case with two novel TSC2 mutations. | Pathol Res Pract | 2025 | 40174278 | PubTator, text mining | PubMed |
| Pleural Metastasis as an Initial Presentation of Prostate Cancer: Case Report and Literature Review. | Diagnostics (Basel) | 2025 | 40150008 | PubTator, text mining | PubMed |
| Unveiling the enigma: Thyroid-like follicular carcinoma of the left kidney. | J Pak Med Assoc | 2025 | 40143489 | PubTator, text mining | PubMed |
| RCC-Ma loss predicts poor survival and metastatic risk in clear cell renal cell carcinoma. | Pathol Res Pract | 2025 | 40121794 | PubTator, text mining | PubMed |
| A case report on metastatic prostate cancer with normal PSA level diagnosed by immunohistochemistry and its management. | Ann Med Surg (Lond) | 2025 | 40109584 | PubTator, text mining | PubMed |
| Whole exome sequencing identified mutations of forkhead box I 1 (FOXI1), keratin 6 C (KRT6C) and gap junction protein delta 2 (GJD2) in a low-grade oncocytic tumor of the kidney: a case report. | Diagn Pathol | 2025 | 39980061 | PubTator, text mining | PubMed |
| Exploring the efficacy of AMACR, ERG, and AR immunostains in prostatic adenocarcinoma and their association with novel grade groups. | Eur J Histochem | 2025 | 39931952 | PubTator, text mining | PubMed |
| Cytomorphology and clinicopathologic correlation of TFE3-rearranged renal cell carcinoma. | Cancer Cytopathol | 2025 | 39912368 | PubTator, text mining | PubMed |
| Hemangioma-Like Clear Cell Renal Cell Carcinoma Exhibiting Aggressive Behavior and High Stage: A Case Report. | Int J Surg Pathol | 2025 | 39905771 | PubTator, text mining | PubMed |
| What's inside. | Indian J Urol | 2025 | 39886628 | PubTator, text mining | PubMed |
| The Role of Immunohistochemistry for AMACR/p504s and p63 in Distinguishing Prostate Cancer from Benign Prostate Tissue Samples in Botswana. | Res Rep Urol | 2025 | 39872294 | PubTator, text mining | PubMed |
| [Aggressive mucinous tubular and spindle cell carcinoma of the kidney: a clinicopathological and genetic analysis of four cases]. | Zhonghua Bing Li Xue Za Zhi | 2025 | 39762168 | PubTator, text mining | PubMed |
| Fumarate hydratase-deficient renal cell carcinoma: a single institution-based study of 29 patients by clinicopathological, immunohistochemical and genetic approaches. | Pathology | 2025 | 39613564 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23600/papers?page=5